Status:
UNKNOWN
The Study of Voriconazole Trough Level in the First Two Weeks After Administration in King Chulalongkorn Memorial Hospital.
Lead Sponsor:
Chulalongkorn University
Conditions:
Voriconazole
Fungal Infection
Eligibility:
All Genders
18-80 years
Brief Summary
Invasive fungal infections are a significant cause of morbidity and mortality in immunocompromised host such as prolong neutropenic patients , post transplantation patients, malignancies or advanced A...
Eligibility Criteria
Inclusion
- Thai patient in King Chulalongkorn Memorial Hospital , age between 18 and 80 years old
- Receiving Voriconazole for treatment or prophylaxis invasive fungal infection
Exclusion
- Severe hepatic or renal dysfunction
- Pregnancy
- Presence of history of allergy to any Azole antifungal agents
- Death within 2 weeks after treatment of invasive fungal infection
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2018
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT03260634
Start Date
January 1 2016
End Date
January 1 2018
Last Update
August 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chulalongkorn university
Bangkok, Thailand, 10330